Mizuho Markets Cayman LP Decreases Stock Position in GE HealthCare Technologies Inc. $GEHC

Mizuho Markets Cayman LP decreased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 96.1% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 15,566 shares of the company’s stock after selling 384,434 shares during the period. Mizuho Markets Cayman LP’s holdings in GE HealthCare Technologies were worth $1,169,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the stock. Moors & Cabot Inc. boosted its stake in GE HealthCare Technologies by 78.9% in the 3rd quarter. Moors & Cabot Inc. now owns 17,073 shares of the company’s stock worth $1,282,000 after purchasing an additional 7,531 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its position in GE HealthCare Technologies by 30.1% during the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 40,022 shares of the company’s stock worth $3,006,000 after purchasing an additional 9,265 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in GE HealthCare Technologies by 8.4% during the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 593,450 shares of the company’s stock valued at $44,558,000 after purchasing an additional 46,097 shares in the last quarter. Laird Norton Wetherby Wealth Management LLC raised its holdings in shares of GE HealthCare Technologies by 4.9% in the third quarter. Laird Norton Wetherby Wealth Management LLC now owns 5,131 shares of the company’s stock worth $385,000 after buying an additional 241 shares during the last quarter. Finally, Larson Financial Group LLC raised its holdings in shares of GE HealthCare Technologies by 1.6% in the third quarter. Larson Financial Group LLC now owns 10,680 shares of the company’s stock worth $802,000 after buying an additional 164 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on GEHC. Stifel Nicolaus boosted their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a report on Wednesday, February 4th. Evercore raised their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their price target for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. BTIG Research boosted their price target on GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Finally, Wall Street Zen raised GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Stock Up 2.0%

NASDAQ:GEHC opened at $72.17 on Tuesday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The company’s fifty day moving average price is $80.53 and its 200-day moving average price is $78.53. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $89.77. The firm has a market capitalization of $32.89 billion, a P/E ratio of 15.83, a PEG ratio of 1.56 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.